Research Associate III, Preclinical Sciences

Manager / Sr. Manager, Upstream Manufacturing

Director / Sr. Director, Internal Manufacturing

Internship IT Systems Analyst

Internship HR Generalist

Research Associate, Antibody Discovery (temporary)

Jr. Buyer, Procurement (temporary)

Quality Control Analyst

Associate Director, Program Management

SRA / Associate Scientist (temporary)

Sr. Director, CMC Quality

Director, Sr. Director Clinical Science Autoimmunity

Patent Agent / Attorney

Manager/Sr. Manager, Statistical Programming

Statistical Programmer/Senior Statistical Programmer

Quality Control Analyst (Temporary)

Senior Biosample Operations Manager

Project Manager, CMC

Manager/Sr. Manager, Clinical Quality Assurance (CQA)

Manager, Pharmacovigilance Operations

Clinical Biomarkers Lead - Oncology

Associate Director/Director, Biostatistics

Clinical Biomarkers Lead - Autoimmunity

Senior Research Associate / Associate Scientist, Translational Research

Executive Administrative Assistant

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acutis Diagnostics

Adagio Therapeutics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Ansa Biotechnologies

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Aruvant

Ascidian Therapeutics

Ascribe Bioscience

IGM Biosciences is pioneering the development of IgM antibodies to treat disease. Current antibody therapies commonly use the Y-shaped IgG structure to bind specific targets; however, the IgM antibody structure may have greater binding power. IgG antibodies possess two binding units, while IgM antibodies have ten. IGM is using this structural baseline to create “super-antibodies” by improving the qualities of IgM antibodies and allowing production at scale. Increased binding avidity and affinity enables IGM to design IgM antibodies to target difficult antigens and also bind multiple targets simultaneously, opening up the translational capabilities of their products to different diseases from cancer to autoimmune. Clinical trials for Non-Hodgkin’s lymphoma are in progress.

<p>IGM Biosciences is pioneering the development of IgM antibodies to treat disease. Current antibody therapies commonly use the Y-shaped IgG structure to bind specific targets; however, the IgM antibody structure may have greater binding power. IgG antibodies possess two binding units, while IgM antibodies have ten. IGM is using this structural baseline to create “super-antibodies” by improving the qualities of IgM antibodies and allowing production at scale. Increased binding avidity and affinity enables IGM to design IgM antibodies to target difficult antigens and also bind multiple targets simultaneously, opening up the translational capabilities of their products to different diseases from cancer to autoimmune. Clinical trials for Non-Hodgkin’s lymphoma are in progress.</p>


IGM Biosciences

Find a biotech startup job.